Literature DB >> 32643137

Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2.

Tom Le Voyer1, David Boutboul2,3, Albane Ledoux-Pilon4, Flore Sicre de Fontbrune5, Guilaine Boursier6, Sylvain Latour7, Guillaume Le Guenno8.   

Abstract

Year:  2020        PMID： 32643137     DOI： 10.1007/s10875-020-00812-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  6 in total

Review 1.  Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.

Authors:  Rakesh Kumar Pilania; Aaqib Zaffar Banday; Saniya Sharma; Rajni Kumrah; Vibhu Joshi; Sathish Loganathan; Manpreet Dhaliwal; Ankur Kumar Jindal; Pandiarajan Vignesh; Deepti Suri; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

Review 2.  Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.

Authors:  Benzeeta Pinto; Prateek Deo; Susmita Sharma; Arshi Syal; Aman Sharma
Journal:  Clin Rheumatol       Date:  2021-03-31       Impact factor: 2.980

3.  Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.

Authors:  Stuart G Tangye; Isabelle Meyts; Jin Yan Yap; Leen Moens; Ming-Wei Lin; Alisa Kane; Anthony Kelleher; Catherine Toong; Kathy H C Wu; William A Sewell; Tri Giang Phan; Georgina E Hollway; Karen Enthoven; Paul E Gray; Jose Casas-Martin; Carine Wouters; Lien De Somer; Michael Hershfield; Giorgia Bucciol; Selket Delafontaine; Cindy S Ma
Journal:  J Clin Immunol       Date:  2021-10-17       Impact factor: 8.317

Review 4.  Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.

Authors:  Sara Signa; Arinna Bertoni; Federica Penco; Roberta Caorsi; Alessia Cafaro; Giuliana Cangemi; Stefano Volpi; Marco Gattorno; Francesca Schena
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

Review 5.  Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations.

Authors:  Hasan Hashem; Dimana Dimitrova; Isabelle Meyts
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

6.  Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Authors:  Hasan Hashem; Giorgia Bucciol; Seza Ozen; Sule Unal; Ikbal Ok Bozkaya; Nurten Akarsu; Mervi Taskinen; Minna Koskenvuo; Janna Saarela; Dimana Dimitrova; Dennis D Hickstein; Amy P Hsu; Steven M Holland; Robert Krance; Ghadir Sasa; Ashish R Kumar; Ingo Müller; Monica Abreu de Sousa; Selket Delafontaine; Leen Moens; Florian Babor; Federica Barzaghi; Maria Pia Cicalese; Robbert Bredius; Joris van Montfrans; Valentina Baretta; Simone Cesaro; Polina Stepensky; Neven Benedicte; Despina Moshous; Guillaume Le Guenno; David Boutboul; Jignesh Dalal; Joel P Brooks; Elif Dokmeci; Jasmeen Dara; Carrie L Lucas; Sophie Hambleton; Keith Wilson; Stephen Jolles; Yener Koc; Tayfun Güngör; Caroline Schnider; Fabio Candotti; Sandra Steinmann; Ansgar Schulz; Chip Chambers; Michael Hershfield; Amanda Ombrello; Jennifer A Kanakry; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-07-29       Impact factor: 8.542
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.